1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. RENOVORX INC

RenovoRx Inc

XNAS: RNXT

Download real time

0.77 -0.02 (-2.53%)

New 52W Low today

104.9K XNAS Volume

XNAS 11 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
14W
2O
0T
28.1

Market Cap

Below industry Median
-3.2

PE TTM

Negative PE TTM
-0.2

PEG TTM

PEG TTM is negative
4

Price to Book

Below industry Median
0.3

Beta 1Year

Very Low volatility


Insider Trading disclosures for RenovoRx Inc

The latest disclosure was made by Ramtin Agah in RenovoRx Inc where a trade of 30,000 Common Stock done at an average price of $0.8 was reported to US exchanges on April 9, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ramtin Agah Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.81 per share. 09 Apr 2025 30,000 1,078,460 - 0.8 24,399 Common Stock
Shaun R. Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.83 per share. 09 Apr 2025 10,000 312,540 - 0.8 8,300 Common Stock
Ronald B. Kocak VP Controller and PAO Purchase of securities on an exchange or from another person at price $ 0.80 per share. 08 Apr 2025 6,000 6,095 - 0.8 4,800 Common Stock
Ronald B. Kocak VP Controller and PAO Purchase of securities on an exchange or from another person at price $ 0.80 per share. 08 Apr 2025 95 95 - 0.8 76 Common Stock
Ronald B. Kocak VP Controller and PAO Purchase of securities on an exchange or from another person at price $ 0.79 per share. 08 Apr 2025 6,500 12,595 - 0.8 5,135 Common Stock
Laurence J. Marton Director Purchase of securities on an exchange or from another person at price $ 0.85 per share. 08 Apr 2025 12,050 45,684 - 0.8 10,218 Common Stock
Ramtin Agah Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.84 per share. 08 Apr 2025 26,000 1,048,460 - 0.8 21,840 Common Stock
Shaun R. Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.83 per share. 07 Apr 2025 10,000 302,540 - 0.8 8,300 Common Stock
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Robert J. Spiegel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2024 25,099 25,099 - - Stock Options (right to buy)
Leesa Gentry Chief Clinical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 190,000 190,000 - - Options
B. Ronald Kocak VP, Controller and PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 15,000 15,000 - - Options
Kirsten Macfarlane Angela Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Common Stock
Robert Spiegel J. Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Common Stock
R. Shaun Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 292,540 - - Common Stock
Macfarlane Angela Kirsten Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrant Shares
Agah Ramtin Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
J. Robert Spiegel Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
R. Bagai Shaun Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 40,983 - - Warrants
J. Marton Laurence Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 8,196 8,196 - - Warrants
Ramtin Agah Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 40,983 47,460 - - Common Stock
Marton Laurence J. Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 26 Jan 2024 8,196 33,634 - - Common Stock
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 125,132 125,132 - - Stock Option
R. Shaun Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 250,263 250,263 - - Stock Option
Nelms Angela Gill Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 33,768 33,768 - - Stock Option
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 125,132 125,132 - - Stock Option
Bagai R. Shaun Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 66,973 66,973 - - Stock Option
Agah Ramtin Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2024 28,424 28,424 - - Stock Option
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 32,500 32,500 - - Employee Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 65,000 65,000 - - Employee Stock Option (right to buy)
Shaun R. Bagai Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2023 130,000 130,000 - - Employee Stock Option (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2022 25,099 25,099 - - Stock Option (right to buy)
Angela Gill Nelms Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2022 274,230 274,230 - - Employee Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.93 per share. 07 Jun 2022 5,182 6,477 - 1.9 10,001 Common Stock
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 1,295 - 0 Common Stock
Ramtin Agah Director, Chief Medical Officer, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 07 Jun 2022 975,000 975,000 - 0 Common Stock
Shaun R. Bagai Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.05 per share. 19 May 2022 5,500 251,557 - 2.1 11,275 Common Stock
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
Laurence J. Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 9,165 9,165 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock Option (right to buy)
Shaun R. Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 48,313 48,313 - - Employee Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 21,398 21,398 - - Employee Stock Option (right to buy)
Kirsten Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 4,582 4,582 - - Stock option (right to buy)
Una S. Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
Kristen Angela Macfarlane Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 22,307 22,307 - - Stock Option (right to buy)
David Diamond Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 33,461 - - Stock Option (right to buy)
Laurence Marton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 11,154 11,154 - - Stock Option (right to buy)
Ramtin Agah Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 52,203 52,203 - - Employee Stock Option (right to buy)
Shaun R. Bagai Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 117,866 117,866 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters